AstraZeneca just announced the opening of its new South San Francisco location. Bay Area employees from Acerta Pharma, MedImmune, Pearl Therapeutics and AstraZeneca’s TIDE (Technology Innovation & Delivery Excellence) are now located at a single state-of-the-art facility in the Cove at Oyster Point, in the heart of the area’s vibrant biotechnology and technology community.
“The opening of our South San Francisco site is a milestone for AstraZeneca, enabling talent from four organizations to work side-by-side at the center of where biotechnology and high-tech industry intersects. This is a demonstration of our commitment to a strong and visible presence in California, our continued growth through science- and collaboration-led innovation, and our dedication to being a great place to work for current and future employees.” Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer
Custom-designed to encourage collaboration and spark scientific innovation, the site’s facilities are equipped with cutting-edge open lab space and an office environment that incorporates AstraZeneca’s iWork philosophy, an activity-based working approach that embraces industry best practices.
Additional highlights of the purpose-built site include:
“Collaboration is at the core of our culture and a key driver of innovation. The opening of our new South San Francisco site brings together the best of both worlds -- a shared drive across our employee base to advance great science and bring new treatments to patients, while providing an opportunity to tap into the Bay Area’s transformative biotech ecosystem, helping to foster great progress internally and externally." Bahija Jallal President of MedImmune and Executive Vice President of AstraZeneca
121 Oyster Point Blvd.
South San Francisco, CA 94080
3:00 - 3:30 pm Registration
3:30 - 5:00 pm Overview and Facility Tour of New AstraZeneca Office and Lab Space
Participation is Limited to 50 Guests
Open to ISPE Members and AstraZeneca Employees Only
Logan Kelley, Senior Project Manager, BioMarin Pharmaceutical Inc.